Bayer said Thursday it has acquired camelina germplasm, intellectual property, and materials from Smart Earth Camelina Corp.

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Bayer's projected earnings decline and litigation pressures affect its outlook. Find out why BAYRY stock might face ...

Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage ...

The net result of that is that Bayer can’t meet the desires of an increasingly vocal group of investors who are seeking a break-up of the group into its constituent pharmaceutical, consumer ...

The German pharmaceutical and agricultural conglomerate said the Federal Court of Australia closed the last pending case in ...

The Bayer Group has announced its full-year financial results for 2012, which turned out to be very successful for all subgroups. As a whole, sales for the Group grew by 8.8% to €39,760 million ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Bayer acquires camelina germplasm and intellectual property assets from Smart Earth Camelina to meet growing demand for ...

Bayer's Global Capability Centre in Hyderabad contributes to R&D, data science, and AI-driven healthcare solutions, ...

The company said, “Bayer (BAYRY) has confirmed its 2024 Group guidance for currency- and portfolio-adjusted sales growth, currency-adjusted core earnings per share, and free cash flow.

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Trendlines Group Ltd. has announced the dissolution of the Bayer Trendlines Agtech Fund, originally set to ...